EMA is establishing a task force for the
implementation of international standards for the identification of
medicinal products for human use in the EU. The task force will be
made up of representatives of the agency, national competent
authorities, the pharmaceutical industry, and service providers.
Parties interested in participating are invited to
submit their expressions of interest by March 6,
2015.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.